Sage Journals: Discover world-class research

Abstract

Objectives:

This clinical update review focuses on the management of cognition and the neuropsychiatric features of Alzheimer’s disease (AD) and highlights current issues regarding pharmacological and non-pharmacological treatment, putative therapeutics and recent relevant research findings in this area.

Conclusions:

AD is a neurodegenerative progressive condition characterised by cognitive impairment and functional decline. Most people with AD will demonstrate neuropsychiatric features, better known as behavioural and psychological symptoms of dementia (BPSD). Early recognition and treatment of BPSD are essential, as these cause considerable distress and carer burden. While there are many disease-modifying therapies for the cognitive symptoms still in the research stage, only symptomatic treatments are currently available for these and the BPSD.

Keywords

alzheimer’s disease behavioural and psychological symptoms of dementia psychiatry neuropsychiatric symptoms

Get full access to this article

View all access options for this article.

References

Eratne

Loi

Farrand

et al . Alzheimer’s Disease Paper 1: Clinical Update on Epidemiology, Pathophysiology and Diagnosis. Australas Psychiatr 2018: in press.

Loi

Westphal

Ames

et al . Minimising psychotropic use for behavioural disturbance in residential aged care. Aust Fam Physician 2015; 44: 180–184.

Loi

Wanasinghage

Goh

et al . A pilot study investigating the feasibility of Symptom Assessment Manager (SAM), a web-based real time tool for monitoring challenging behaviours. Int J of Geriatric Psychiatr 2018; 33: 576–582.

Hodges

McKinnon Kelso

et al . Dementia Australia Quality Dementia Care Series 5, Younger onset dementia: a practical guide, 2015 revision. Sydney: Alzheimer’s Australia.

Banerjee

Hellier

Dewey

et al . Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet 2011; 378: 403–411.

The Royal Australian and New Zealand College of Psychiatrists. Professional Practice Guideline 10: antipsychotic medications as a treatment of behavioural and psychological symptoms of dementia. https://www.ranzcp.org/Files/Resources/College_Statements/Practice_Guidelines/pg10-pdf.aspx (2016, accessed 12 December 2017).

Husebo

Ballard

Sandvik

et al . Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trials. BMJ 2011; 343: d4065.

Franchi

Pharmacological management of behavioural and psychological symptoms of dementia. J Pharmacy Pract and Res 2016; 46: 277–285.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.33 MB